Doctor profile · Federal record

Dr. Mohamed Sebai, M.D.

Specialist (CMS: Rheumatology) · Upland, CA

  • NPI 1760481915
  • Accepts Medicare
  • MIPS 0.0 / 100 · 2023
  • 46 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1238 E Arrow Hwy
Upland, CA 917864951
(909) 982-0099
fax (909) 931-0402

Credentials & registration

NPPES · NUCC
NPI registered
July 2005 — 21 yrs on file
Profile last updated
September 27, 2012
Year of graduation
1980 — 46 yrs since
Specialty taxonomy
174400000X — NUCC code
State license (1)
California #A50851
Medicaid
CA #GR0091870

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1760481915. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
26,090
Distinct HCPCS
10
Medicare allowed
$849,602
HCPCS Description Services Patients Avg allowed
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 8,725 16 $39
J1745 Injection, infliximab, excludes biosimilar, 10 mg 6,325 24 $33
J0897 Injection, denosumab, 1 mg 3,000 37 $23
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 890 72 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 685 199 $132
96372 Injection of drug or substance under skin or into muscle 573 112 $15
36415 Insertion of needle into vein for collection of blood sample 556 135 $8
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated 555 135 $4
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 551 134 $8
80053 Blood test, comprehensive group of blood chemicals 550 135 $10

In context: peer comparison

Among 2 peers in Upland Specialist, average services per provider: 555. This provider delivers 47× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,351
Transactions
69
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
Amgen INC. 28 $479.56
GlaxoSmithKline, LLC. 10 $175.56
US Oncology Corporate, INC. 1 $173.84
Novartis Pharmaceuticals Corporation 10 $141.16
Pfizer INC. 4 $92.49
Abbvie INC. 5 $83.17
Ucb, INC. 4 $79.20
Organon LLC 2 $35.25
Sandoz INC. 2 $29.80
Ani Pharmaceuticals, INC. 1 $26.16
Boehringer Ingelheim Pharmaceuticals, INC. 1 $19.18
E.R. Squibb & Sons, L.L.C. 1 $15.50

By nature of payment

Food and Beverage
$1,351

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,082
Patients
350
Total drug cost
$339,318
Drug Type Claims Patients Total cost
Gabapentin Generic 168 62 $6,311
Hydroxychloroquine Sulfate Generic 126 44 $11,710
Alendronate Sodium Generic 103 36 $1,926
Methotrexate (Methotrexate Sodium) Brand 101 37 $6,703
Prednisone Generic 100 33 $1,204
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 80 13 $1,382
Sulfasalazine Generic 69 19 $3,384
Diclofenac Sodium Generic 65 27 $1,934
Tramadol Hcl Generic 56 15 $298
Duloxetine Hcl Generic 43 14 $1,452

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Mohamed Sebai's medical specialty?
Dr. Mohamed Sebai practices Specialist in Upland, CA.
Where does Dr. Mohamed Sebai practice?
Dr. Mohamed Sebai practices at 1238 E Arrow Hwy, Upland, CA 917864951. Office phone: 9099820099.
What is Dr. Mohamed Sebai's NPI?
Dr. Mohamed Sebai's National Provider Identifier (NPI) is 1760481915, issued by NPPES.
Does Dr. Mohamed Sebai accept Medicare assignment?
Yes. Dr. Mohamed Sebai accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mohamed Sebai commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.